Navigation Links
Research-Based Biopharmaceutical Company Awards Trials to DATATRAK
Date:8/25/2009

CLEVELAND, Aug. 25 /PRNewswire-FirstCall/ -- DATATRAK International, Inc.(OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of two new studies with a global research-based biopharmaceutical company. The award includes a multi-site, five-year study and demonstrates a long-term commitment to the DATATRAK eClinical(TM) platform.

"We are pleased that our partnership with this biopharmaceutical continues to grow," said Laurence Birch, DATATRAK's Chairman of the Board. "The signing of new business with existing clients validates our technology and service delivery model, DATATRAK ONE(TM). Our Enterprise Transfer clients are able to successfully develop and deliver trials utilizing DATATRAK's technology and online resources."

DATATRAK eClinical(TM) empowers clinical users and service providers with the tools necessary for efficiently conducting, delivering and managing clinical trials. Built upon a unified architecture, eClinical's Clinical Suite, Trial Manager, Enterprise Manager and Enterprise Platform components provide the foundation for end-to-end Clinical Trial Solutions. Whether deploying products via DATATRAK's Enterprise Transfer program or relying on the DATATRAK team for project delivery as a Software as a Service (SaaS) client, DATATRAK provides the most complete product and service offering for the Clinical Trial Life Cycle.

About DATATRAK International, Inc.

DATATRAK International, Inc. is a worldwide technology company focused on the provision of multi-component eClinical solutions and related services for the clinical trials industry. We operate under the concept of DATATRAK ONE(TM), which encompasses our unique, single platform technology. The singular architecture of our DATATRAK eClinical(TM) product suite has been embraced by clients around the globe for its ability to ef
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
2. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
3. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
4. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
5. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
6. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
7. XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma
8. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
9. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
10. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
11. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... R.I. , Aug. 21, 2014 CVS Caremark ... tender results, applicable Reference Yields and consideration payable in connection ... commenced on August 7, 2014 for (1) any and all ... All Notes") and (2) up to a maximum amount of ... 2041 and 5.750% Senior Notes due 2017 (collectively, the "Maximum ...
(Date:8/21/2014)... Aug. 21, 2014  Cyberonics, Inc. (NASDAQ: CYBX ... 2014.  Quarterly highlights 1   ... to the first quarter of fiscal 2014, and other achievements, ... an increase of 6.8%; , Strong international net sales ... currency basis; , U.S. net product sales reached a ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... CITY, Mo., March 16, 2012  Argus Health Systems Inc., ... a National Council for Prescription Drug Programs (NCPDP) focus ... growing biopharmaceuticals industry. John Hill, vice ... NCPDP focus group. The NCPDP focus group, ...
... March 16, 2012 Echo Therapeutics, Inc. (Nasdaq: ... tCGM System as a non-invasive, wireless, transdermal continuous glucose ... drug delivery, today announced financial results for the year ... 10-K is available through Echo,s website at www.echotx.com ...
Cached Medicine Technology:Echo Therapeutics, Inc. Announces 2011 Financial Results 2Echo Therapeutics, Inc. Announces 2011 Financial Results 3Echo Therapeutics, Inc. Announces 2011 Financial Results 4Echo Therapeutics, Inc. Announces 2011 Financial Results 5
(Date:8/21/2014)... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast, 2012 - 2018," ... 236.1 million in 2011 and is estimated to reach ... a CAGR of 6.3% from 2012 to 2018. , ... . , Fundus cameras market growth in recent years ...
(Date:8/21/2014)... The worlds of personal care and ... chance to grab free products. BaliniSports will ... of Maine with all qualifying purchases for a limited ... friendly yoga apparel is simply perfect,” said Ada Hung, ... the two brands is intended to give people in ...
(Date:8/21/2014)... 21, 2014 Tibet has long been ... mysterious mountaintop kingdom. Prayers flags whip in the ... the low rumble of chanting monks fill the otherwise ... the world’, access to Tibet is challenging due to ... land can prove to be daunting for even the ...
(Date:8/21/2014)... David Mullings’ new book, Things #Entrepreneurs Say, ... of quotes from famous entrepreneurs to the not so ... on their challenging paths towards success. Earth Source Organics ... President and Founder Audrey Darrow alongside the bits of ... such as Oprah Winfrey, Steve Jobs, and Richard Branson, ...
(Date:8/21/2014)... 2014 Aspen Advisors, a U.S.-based healthcare consulting ... of Modern Healthcare’s Best Places to Work in Healthcare ... the healthcare industry for creating workplaces that enable employees to ... on employee responses to an employee engagement and satisfaction survey. ... has been named a “Best Places to Work in ...
Breaking Medicine News(10 mins):Health News:Fundus Cameras Market: Product Type- Mydriatic, Non-Mydriatic, Hybrid and ROP Cameras; End Users- Hospitals, Ophthalmology Clinics and Ophthalmic & Optometrist Offices 2Health News:Tom's of Maine Partner up with BaliniSports Yoga Apparel 2Health News:Earth Source Organics President Audrey Darrow Featured in New David Mullings Book 2Health News:Modern Healthcare Names Aspen Advisors Among the Top 100 Employers in the Healthcare Industry for a Fourth Consecutive Year 2
... on Series of Nationwide Investor MeetingsTUCSON, Ariz., May 8 ... ) today announced that, in connection with management,s upcoming meetings ... Securities and Exchange Commission its Spring 2009 Investor Presentation. ... free at the SEC,s website at http://www.sec.gov ...
... The federal government has made tax incentives accessible for ... implementation of simple automation into new or existing facilities ... a positive impact on organizations purchasing automated carousels and ... efficiencies and a high internal rate of return. The ...
... Six-Fold and Recurring Handpiece Sales Increase 22% on Comparable ... (OTC Bulletin Board: MLSS), the recognized leader in advanced ... for the three months ended March 31, 2009. ... 2009 with Three Months Ended March 31, 2008: ...
... N.J., May 8 Quest Diagnostics Incorporated (NYSE: ... and services, will conduct its annual meeting of shareholders on ... webcast will be accessible through the Investor Relations section of ... For those unable to listen to the live broadcast, ...
... Inc. (NTI(R)) (Nasdaq: NTII ) today announced ... March 31, 2009.Revenues for the third quarter of fiscal ... the third quarter of fiscal 2008. Research and development ... March 31, 2009 compared to $5.9 million for the ...
... Universal Capital Management, Inc. (OTC Bulletin Board: ... provides management and strategic growth resources to emerging ... Corporation ("Vystar") and Alatech Healthcare, LLC announced 510(k) ... (FDA) to market and sell Alatech,s Envy(TM) condom ...
Cached Medicine News:Health News:Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available 2Health News:Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available 3Health News:Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available 4Health News:Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available 5Health News:Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available 6Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 2Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 3Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 4Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 5Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 6Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 7Health News:Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results 2Health News:Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results 3Health News:Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results 4Health News:Universal Capital Management Reports Vystar(TM) Corporation Receives FDA Clearance for Envy(TM) Natural Rubber Latex Condom Made with Vytex(TM) NRL 2Health News:Universal Capital Management Reports Vystar(TM) Corporation Receives FDA Clearance for Envy(TM) Natural Rubber Latex Condom Made with Vytex(TM) NRL 3Health News:Universal Capital Management Reports Vystar(TM) Corporation Receives FDA Clearance for Envy(TM) Natural Rubber Latex Condom Made with Vytex(TM) NRL 4
Desmarres Retractor Size 4...
Desmarres Lid Retractor thin solid blades. Size 2....
... system introduces a new level ... microsurgical instrumentation. It has an ... with advanced microcomputer control of ... operate with a full range ...
Multiple Modulation Phaco (MMP) programmability with eight surgeon settings for maximum versatility. The combination of the peristaltic power balanced pump and the piezoelectric handpiece results in ...
Medicine Products: